Largest Cannabis Stocks by Market Cap
Updated March 2026The biggest cannabis companies by market capitalization. Industry leaders ranked from largest to smallest.
Market capitalization is the most fundamental measure of a publicly traded company's size, calculated by multiplying the stock price by the total number of shares outstanding. In cannabis, the largest companies by market cap are the industry's blue chips — the names that attract the most analyst coverage, have the deepest liquidity, and serve as bellwethers for sector sentiment.
The composition of the cannabis market cap leaderboard has shifted over the years. In 2018-2020, Canadian LPs dominated the top spots, fueled by retail investor enthusiasm around Canadian legalization. As the US cannabis market matured, MSOs climbed the rankings based on superior revenue growth and larger addressable markets. Today's leaderboard typically includes a mix of MSOs, LPs, ancillary companies, REITs, and biotechs — reflecting the sector's increasing diversification.
The top 20 cannabis stocks by market cap are listed below. These companies collectively represent the majority of the sector's total market capitalization and are the most widely held cannabis equities among both retail and institutional investors. For portfolio construction purposes, these large-cap names typically offer lower volatility and better liquidity than smaller cannabis stocks, though they may also offer less upside potential in a strong bull market.
Largest Cannabis Stocks by Market Cap — Full Rankings
20 stocks · Ranked by market cap
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals | $178.55 | -1.66% | $10.99B | $4.16B | — | 2.64x | $10.99B |
| 2 | SMG | Scotts Miracle-Gro | $60.96 | +0.96% | $3.54B | $3.35B | 25.0% | 1.06x | $3.54B |
| 3 | CURLF | Curaleaf Holdings | $2.36 | +2.83% | $1.80B | $0 | — | — | $1.80B |
| 4 | TPB | Turning Point Brands | $90.62 | +0.69% | $1.73B | $463.1M | 55.9% | 3.75x | $1.73B |
| 5 | GTBIF | Green Thumb Industries | $6.56 | +7.01% | $1.54B | $0 | — | — | $1.54B |
| 6 | IIPR | Innovative Industrial Properties | $52.66 | -2.34% | $1.48B | $276.0M | — | 5.37x | $1.48B |
| 7 | TCNNF | Trulieve Cannabis | $6.40 | +4.92% | $1.22B | $0 | — | — | $1.22B |
| 8 | CRON | Cronos Group | $2.50 | +0.81% | $947.6M | $146.6M | 36.4% | 6.46x | $947.6M |
| 9 | TLRY | Tilray Brands | $6.89 | -1.57% | $802.7M | $837.3M | 26.4% | 0.96x | $802.7M |
| 10 | MSOS | AdvisorShares Pure US Cannabis ETF | $3.82 | +1.33% | $764.3M | $0 | — | — | $764.3M |
| 11 | GLASF | Glass House Brands | $7.50 | -2.72% | $608.3M | $0 | — | — | $608.3M |
| 12 | VRNOF | Verano Holdings | $1.26 | -8.70% | $457.6M | $0 | — | — | $457.6M |
| 13 | SNDL | SNDL Inc | $1.51 | -5.03% | $388.8M | $0 | — | — | $388.8M |
| 14 | CGC | Canopy Growth | $1.02 | -2.86% | $385.4M | $278.4M | 28.8% | 1.38x | $385.4M |
| 15 | KERN | Akerna Corp | $6.27 | +24.64% | $376.3M | $6.8M | 402.0% | 55.05x | $376.3M |
| 16 | NLCP | NewLake Capital Partners | $15.43 | -1.09% | $370.3M | $0 | — | — | $370.3M |
| 17 | INNPF | InnocanPharma | $5.07 | 0.00% | $354.9M | $0 | — | — | $354.9M |
| 18 | CRLBF | Cresco Labs | $0.97 | -0.27% | $346.1M | $0 | — | — | $346.1M |
| 19 | VFF | Village Farms International | $2.87 | -6.51% | $331.5M | $253.3M | 38.7% | 1.31x | $331.5M |
| 20 | PLNHF | Planet 13 Holdings | $0.91 | +5.21% | $295.8M | $0 | — | — | $295.8M |
Top 3 Spotlight
Jazz Pharmaceuticals
Jazz Pharmaceuticals ranks #1 in the largest cannabis stocks by market cap category with a share price of $178.55 and a market capitalization of $10.99B. The company operates in the Biotech sector and is listed on the NASDAQ. With trailing twelve-month revenue of $4.16B and a gross margin of N/A, JAZZ represents the top-ranked stock in this category based on market cap.
Scotts Miracle-Gro
Scotts Miracle-Gro ranks #2 in the largest cannabis stocks by market cap category with a share price of $60.96 and a market capitalization of $3.54B. The company operates in the Ancillary sector and is listed on the NYSE. With trailing twelve-month revenue of $3.35B and a gross margin of 25.0%, SMG represents the second-ranked stock in this category based on market cap.
Curaleaf Holdings
Curaleaf Holdings ranks #3 in the largest cannabis stocks by market cap category with a share price of $2.36 and a market capitalization of $1.80B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, CURLF represents the third-ranked stock in this category based on market cap.
Methodology
All cannabis companies tracked by CannaCap are ranked in descending order by market capitalization. This list shows the top 20 largest companies regardless of sector, geography, or other filters. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 20 qualifying stocks out of 100 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the largest cannabis stocks by market cap category is JAZZ (Jazz Pharmaceuticals) with a market cap of $10.99B. The stock trades at $178.55 per share with a market capitalization of $10.99B. In second place is SMG ($3.54B), followed by CURLF ($1.80B) in third.
Across all 20 qualifying stocks, the average share price is $22.71 and the average market capitalization is $1.44B. The combined trailing twelve-month revenue of all companies in this category is $9.77B. The average gross margin among companies with positive margins is 87.6%. The average price-to-sales ratio is 8.66x.
The most represented sector in this category is MSO with 7 out of 20 companies (35%). Among the ranked stocks, 9 are trading higher today while 10 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the largest cannabis stocks by market cap category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by market cap may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
Even the largest cannabis companies carry significant risk relative to blue-chip stocks in mature industries. Cannabis remains federally illegal in the United States, creating regulatory uncertainty that can impact any company in the sector regardless of size. Large-cap cannabis stocks can experience 20-40% drawdowns during sector sell-offs driven by legislative disappointments, earnings misses, or broader market risk-off events. Some of the largest cannabis companies by market cap have achieved that status through aggressive acquisition strategies funded by debt or equity, which may not have generated attractive returns on invested capital. Size alone does not insulate a cannabis company from the structural challenges facing the industry.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
What is considered large-cap in cannabis?
The definition of large-cap in cannabis is very different from the broader stock market. In mainstream equities, large-cap typically means market caps above $10 billion. In cannabis, a company with a market cap above $2-3 billion is considered large-cap, and even companies above $1 billion are substantial players. The entire publicly traded cannabis sector's combined market cap is roughly $30-50 billion, compared to individual tech companies worth $1-3 trillion. This smaller scale means cannabis large-caps are more comparable to small-cap or micro-cap stocks in the broader market in terms of volatility and liquidity.
Are large-cap cannabis stocks less risky than small-cap?
Generally yes, but the risk reduction is relative, not absolute. Large-cap cannabis stocks tend to have more diversified operations, stronger balance sheets, better management teams, and more liquid trading markets. However, they still face all the sector-wide risks of federal prohibition, 280E taxation, and regulatory uncertainty. During the 2022-2023 cannabis bear market, even the largest MSOs declined 50-70% from their highs. Large-cap cannabis stocks should still be considered high-risk relative to large-cap stocks in legal, mature industries.
How does total cannabis market cap compare to other industries?
The total market capitalization of all publicly traded cannabis companies is roughly $30-50 billion — smaller than a single large tech company like Salesforce or AMD. For context, the US legal alcohol market supports a combined market cap well over $500 billion across major brewers, distillers, and distributors. This enormous gap suggests significant potential for cannabis market cap expansion as the industry matures, gains legal clarity, and attracts institutional capital. Even modest convergence toward alcohol industry valuations would represent massive upside for cannabis equities.
Which sectors dominate the cannabis market cap leaderboard?
The market cap leaderboard is typically led by a mix of US MSOs and Canadian LPs at the top, with ancillary companies, biotech firms, and REITs also represented. MSOs have been gaining market cap share over the past several years as US cannabis revenue has grown while Canadian revenue has stagnated. The specific composition changes as stock prices fluctuate, but generally the top 5-10 companies include well-known names from both the US and Canadian markets.
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.